Pluristem Therapeutics, Inc.

(NASDAQ:PSTI)

0.39

-0.01 (-2.50%)

Dec 01 - Close

Open
0.41
High
0.42
Low
0.30
Vol.
55.15K
Mkt Cap
3.36M
52Wk High
7.75
52Wk Low
0.26
Avg. Vol.
54.70K
P/E (Trailing)
-0.25
Beta
0.30
Short %
0.30%
Div. Yield
—

After-Hours 0.39 0.00 (0.00%) Mon, 1 Dec 2008 6:50 PM

Company Profile

Pluristem Therapeutics, Inc.

MATAM Advanced Tech. Park

Haifa, 31905

Israel - Map

Phone: 972747107171

Fax: 97248501085

Website: www.pluristem.com

State of incorporation: Nevada

CEO: Zami Aberman

Employees: 21

Sector: Healthcare

Industry Group: Drugs

Industry: Biotechnology

Leader in stem cell expansion

The Company is engaged in the business of the development of the Mesenchymal and stem cell production technology and the commercialization of cell therapy products.

Recent news for PSTI

Recent opinions on PSTI

No recent Opinions for PSTI

Top members owning PSTI

  • Top 1%

    boris13

    boris13

    22.61%3m:

    33.48%YTD:

  • Top 3%

    barry_m

    barry_m

    -85.95%3m:

    -85.52%YTD:

  • Top 88%

    moldi13

    moldi13

    -54.88%3m:

    -68.93%YTD:

Members owning PSTI also own

GOOG (100.00%), ALVR (100.00%), CRNT (100.00%), MT (66.67%), ORA (66.67%)

Member sentiment: Neutral